Skip to main content
Clinical Trials/JPRN-UMIN000005103
JPRN-UMIN000005103
Completed
未知

A multi-center randomized controlled trial Comparing Standard Prednisolone therapy with Standard Prednisolone therapy + High-dose Mizoribine for the Treatment of early-relapsing steroid sensitive nephrotic syndrome in children (JSKDC05) - A RCT Comparing Standard Prednisolone therapy with Standard Prednisolone therapy + High-dose Mizoribine for the Treatment of early-relapsing SSNS in children (JSKDC05)

Japanese Study Group of Kidney Disease in Children0 sites120 target enrollmentMarch 1, 2011

Overview

Phase
未知
Intervention
Not specified
Conditions
Steroid sensitive nephrotic syndrome in children
Sponsor
Japanese Study Group of Kidney Disease in Children
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2011
End Date
January 31, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japanese Study Group of Kidney Disease in Children

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\)Other renal nephrotic syndrome(persistent hematuria) (2\)History of Henoch\-Sch\&ouml;nlein nephritis, systemic lupus erythematosus or secondary nephrotic syndrome (3\)History of steroid resistant (4\)History of immunosuppressants administration against nephrotic syndrome (5\)Uncontrollable hypertension (6\)Renal dysfunction(creatinine clearance \< 90 mL/min) (7\)Severe liver dysfunction (8\)Patients enrolling another clinical trials at the first relapse (9\)Judged inappropriate for this study by the physicians

Outcomes

Primary Outcomes

Not specified

Similar Trials